Document is current
Any future updates will be listed below
-
Authors
Colman, Blake D. https://orcid.org/0000-0001-6860-4378
Sanfilippo, Paul G.
Fok, Anthony
Le Nguyen, Minh Ngoc
Kini, Raghuvir
Chakrabarti, Rahul
Sheth, Shivanand
Raviskanthan, Subahari
Del Porto, Lana
Shuey, Neil
Hutton, Elspeth J.
Fielding, Joanne
White, Owen
Fraser, Clare L.
van der Walt, Anneke
- License Information
-
More Information
Article History
Received: 23 July 2024
Revised: 5 December 2024
Accepted: 8 December 2024
First Online: 15 January 2025
Declarations
:
: BDC, PGS, AF, MNLN, RK, RC, SS, SR, NS, EH, and CLF report no conflicts. JF receives funding from Genzyme and Biogen and has received honorarium from Novartis. OW has received honoraria from Novartis, Merck, and Genzyme, and has served on Advisory Boards for Merck, Novartis, Roche, and Biogen. He is Chief Medical Officer for Braineye P/L. LDP has received research funding from Alcon laboratories. AVDW has served on advisory boards for Novartis, Biogen, Merck and Roche and NervGen. She received unrestricted research grants from Novartis, Biogen, Merck, and Roche. She is currently a co-Principal investigator on a co-sponsored observational study with Roche, evaluating a Roche-developed smartphone app, Floodlight-MS. She has received speaker’s honoraria and travel support from Novartis, Roche, Biogen, and Merck. She serves as the Chief operating Officer of the MSBase Foundation (not for profit). Her primary research support is from the National Health and Medical Research Council of Australia and MS Research Australia.
: This study has been approved by the Human Research Ethics Committee of Alfred Health (Project No. 53125, local reference number 312/19).
